Nova Leap Health Corp (NLH) — Capital Reinvestment Ratio
Nova Leap Health Corp (NLH) has a Capital Reinvestment Ratio of 0.10x as of March 2023, meaning it reinvests 0% of its operating cash flow (CA$294.33K) in capital expenditures (CA$27.99K). See debt-free asset ratio of Nova Leap Health Corp to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Nova Leap Health Corp Capital Reinvestment Ratio (2019–2024)
This chart tracks Nova Leap Health Corp's Capital Reinvestment Ratio across 6 annual periods. Check how aggressively does Nova Leap Health Corp reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Nova Leap Health Corp (2019–2024)
Year-by-year Capital Reinvestment Ratio for Nova Leap Health Corp from 2019 to 2024. For live market cap and broader valuation context, see NLH stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.02x | CA$1.39 Million | CA$25.00K | ▲ +38.6% |
| 2023 | 0.01x | CA$2.15 Million | CA$27.99K | ▼ -81.4% |
| 2022 | 0.07x | CA$1.02 Million | CA$71.24K | ▲ +113.6% |
| 2021 | 0.03x | CA$2.18 Million | CA$71.24K | ▲ +1365.2% |
| 2020 | 0.00x | CA$3.01 Million | CA$6.72K | ▼ -91.2% |
| 2019 | 0.03x | CA$613.80K | CA$15.48K | — |